Related Experiment Video
Updated: Dec 15, 2025

10:41
Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
7.8K
Recent genetic advances in early-onset dystonia
Dora Steel1,2, Manju A Kurian1,2
1Developmental Neurosciences, UCL Great Ormond Street Institute of Child Health.
Current Opinion in Neurology
|July 14, 2020
Summary
Recent advances in genetic testing reveal new causes of dystonia, aiding diagnosis. Neurologists can better navigate genetic testing for rare neurological disorders.
Area of Science:
- Genetics
- Neurology
- Rare Diseases
Background:
- Rapid advancements in gene discovery and next-generation sequencing.
- Increasing complexity for practicing neurologists in diagnosing genetic disorders.
- Dystonia presents diagnostic challenges due to numerous genetic causes.
Purpose of the Study:
- Review newly described genetic conditions associated with dystonia.
- Discuss approaches to gene discovery and genetic testing in neurology.
- Provide insights for both research and clinical perspectives.
Main Methods:
- Literature review of recent genetic discoveries in dystonia.
- Analysis of the evolving landscape of genetic testing for neurological disorders.
- Synthesis of research and clinical perspectives on genetic diagnosis.
Main Results:
- Several new genes (ZNF142, GSX2, IRF2BPL, DEGS1, PI4K2A, CAMK4, VPS13D, VAMP2) identified as causes of dystonia.
- Dystonia recognized as a feature in genetic conditions previously linked to epilepsy.
- The DYT classification system has not recognized new gene discoveries since 2016.
Conclusions:
- Despite rapid gene discovery, many dystonia cases remain undiagnosed.
- Clinicians must adapt to the proliferation of rare genetic disorders.
- Rational and adaptive use of genetic testing can accelerate diagnosis.
Related Concept Videos
Parkinson's Disease: Overview
1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Human Genetics
1.3K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.3K
Satellite Stem Cells and Muscular Dystrophy
2.2K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.2K
Sex-linked Disorders
107.2K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
107.2K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
981
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
981

